Atlas Trials

Study of ASLAN004 in Healthy Subjects

Clinical trial NCT03721263 · COMPLETED

Trial details

NCT number
NCT03721263
Sponsor
ASLAN Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Allergic Disorder
Start date
2018-10-15
Primary completion
2019-03-27
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.